Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | +0.40% | -2.33% | -1.37% |
Financials (USD)
Sales 2022 | 18.57M | Sales 2023 | 17.47M | Capitalization | 39.45M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 2.91 x |
Net Debt 2022 | 6.69M | Net Debt 2023 | 15.71M | EV / Sales 2023 | 3.16 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-6.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.64% |
Latest transcript on ImmuCell Corporation
1 day | +2.30% | ||
1 week | -0.49% | ||
Current month | +4.18% | ||
1 month | -1.54% | ||
3 months | -1.06% | ||
6 months | -1.06% | ||
Current year | +0.49% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Corporate Officer/Principal | 68 | 16-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
David Tomsche
CHM | Chairman | 67 | 06-12-20 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 5.02 | +0.40% | 3 966 |
24-05-02 | 5 | 0.00% | 10,413 |
24-05-01 | 5 | +1.83% | 28,675 |
24-04-30 | 4.91 | -3.73% | 18,651 |
24-04-29 | 5.1 | -0.78% | 9,991 |
Delayed Quote Nasdaq, May 03, 2024 at 10:44 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+0.49% | 39.12M | |
+25.09% | 48.09B | |
+47.36% | 40.62B | |
-2.19% | 40.43B | |
-6.20% | 28.36B | |
+7.82% | 24.89B | |
-19.12% | 19.01B | |
+29.38% | 12.09B | |
-0.78% | 11.88B | |
-0.22% | 11.8B |
- Stock Market
- Equities
- ICCC Stock